Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial

Long‐term safety and efficacy of a fixed‐combination halobetasol propionate 0.01%/tazarotene 0.045% lotion in moderate‐to‐severe plaque psoriasis: phase 3 open‐label study

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/jdv.17113 ◽

2021 ◽

Author(s):

M.G. Lebwohl ◽

L. Stein Gold ◽

K. Papp ◽

G. Han ◽

D.M. Pariser ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Long term safety and efficacy of donepezil in the treatment of dementia in Alzheimer's disease in adults with Down syndrome: open label study

International Journal of Geriatric Psychiatry ◽

10.1002/gps.859 ◽

2003 ◽

Vol 18 (6) ◽

pp. 549-551 ◽

Cited By ~ 42

Author(s):

V. P. Prasher ◽

C. Adams ◽

R. Holder ◽

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Down Syndrome ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety and Efficacy of 10 kHz Spinal Cord Stimulation for the Treatment of Refractory Chronic Migraine: A Prospective Long‐Term Open‐Label Study

Neuromodulation Technology at the Neural Interface ◽

10.1111/ner.13465 ◽

2021 ◽

Author(s):

Adnan Al‐Kaisy ◽

Stefano Palmisani ◽

Roy Carganillo ◽

Samuel Wesley ◽

David Pang ◽

...

Keyword(s):

Spinal Cord ◽

Chronic Migraine ◽

Spinal Cord Stimulation ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Refractory Chronic Migraine

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

The Lancet Haematology ◽

10.1016/s2352-3026(20)30323-9 ◽

2020 ◽

Vol 7 (12) ◽

pp. e861-e873 ◽

Author(s):

Paola Tacchetti ◽

Lucia Pantani ◽

Francesca Patriarca ◽

Maria Teresa Petrucci ◽

Elena Zamagni ◽

...

Keyword(s):

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Newly Diagnosed ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Long Term Follow Up

Long-term safety and seizure outcome in Japanese patients with Lennox–Gastaut syndrome receiving adjunctive rufinamide therapy: An open-label study following a randomized clinical trial

Epilepsy Research ◽

10.1016/j.eplepsyres.2016.01.002 ◽

2016 ◽

Vol 121 ◽

pp. 1-7 ◽

Cited By ~ 13

Author(s):

Yoko Ohtsuka ◽

Harumi Yoshinaga ◽

Yukiyoshi Shirasaka ◽

Rumiko Takayama ◽

Hiroki Takano ◽

...

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Japanese Patients ◽

Seizure Outcome ◽

Open Label ◽

Open Label Study ◽

Label Study

Long-Term Safety and Efficacy of Lubiprostone in Opioid-Induced Bowel Dysfunction in Patients with Chronic, Non-Cancer Pain: Results of a Phase 3, Open-Label Clinical Trial Presidential Poster

The American Journal of Gastroenterology ◽

10.14309/00000434-201210001-00322 ◽

2012 ◽

Vol 107 ◽

pp. S138-S139 ◽

Author(s):

Egilius Spierings ◽

Taryn Joswick ◽

Elizabeth Lindner ◽

Fasil Woldegeorgis ◽

Ryuji Ueno

Keyword(s):

Clinical Trial ◽

Cancer Pain ◽

Bowel Dysfunction ◽

Open Label ◽

Phase 3 ◽

Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.v66n0304 ◽

2005 ◽

Vol 66 (03) ◽

pp. 294-299 ◽

Cited By ~ 75

Author(s):

Lenard A. Adler ◽

Thomas J. Spencer ◽

Denái R. Milton ◽

Rodney J. Moore ◽

David Michelson

Keyword(s):

Attention Deficit Hyperactivity Disorder ◽

Attention Deficit ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Hyperactivity Disorder

Long-term Safety and Efficacy of Vigabatrin in Japanese Patients with Infantile Spasms: A Multicenter Open-label Study

Journal of the Japan Epilepsy Society ◽

10.3805/jjes.36.17 ◽

2018 ◽

Vol 36 (1) ◽

pp. 17-31 ◽

Author(s):

Yoko Ohtsuka ◽

Masayuki Horiguchi

Keyword(s):

Japanese Patients ◽

Infantile Spasms ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Safety and efficacy of vemurafenib in BRAFV600E and BRAFV600K mutation-positive melanoma (BRIM-3): extended follow-up of a phase 3, randomised, open-label study

The Lancet Oncology ◽

10.1016/s1470-2045(14)70012-9 ◽

2014 ◽

Vol 15 (3) ◽

pp. 323-332 ◽

Cited By ~ 625

Author(s):

Grant A McArthur ◽

Paul B Chapman ◽

Caroline Robert ◽

James Larkin ◽

John B Haanen ◽

...

Keyword(s):

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽